UC, MIT Battle Over Patent to Gene-Editing Tool
By Lisa M. Krieger,
San Jose Mercury News
| 05. 09. 2015
Will the University of California reap the financial rewards of CRISPR's commercial use, likely worth billions of dollars? That's the source of a bitter fight.
In June 2012, UC Berkeley's Jennifer Doudna and Emmanuelle Charpentier, now a professor in Germany, showed how bacteria's natural defense system could be turned into a "gene editing" tool to cut DNA strands.
Seven months later, Feng Zhang of the Massachsuetts Institute of Technology, along with Harvard's George Church, showed that the tool also works in human cells.
UC and Doudna filed for a patent first. But in a shocking turn of events, MIT and Zhang won last month, earning the patent that covers use of CRISPR in every species except bacteria, including humans.
MIT paid extra to expedite Zhang's patent application. MIT and Zhang also assert that the patent belongs to them because Doudna didn't prove it works in human cells, only bacterial cells.
Zhang also submitted photos of lab notebooks showing his lab work was ahead of Doudna's.
UC and Doudna are fighting back, submitting thousands of pages of documentation to support their...
Related Articles
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Neel Shah, The PrePrint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Eleanor Hayward and Joanna Crawford, The Times | 03.29.2024
Gazing out at the Mediterranean from an idyllic rocky mountaintop, Sophie Hermann announced to her half a million Instagram followers that she had decided to freeze her eggs. Since that post in August, the 37-year-old former Made in Chelsea star...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...